CLOFAZIMINE - A REVIEW OF ITS MEDICAL USES AND MECHANISMS OF ACTION

被引：129

作者：

ARBISER, JL

MOSCHELLA, SL

机构：

[1] HARVARD UNIV,SCH MED,DEPT DERMATOL,BOSTON,MA

[2] LAHEY CLIN FDN,BURLINGTON,MA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1995年 / 32卷 / 02期

关键词：

D O I：

10.1016/0190-9622(95)90134-5

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

Clofazimine has been in clinical use for almost 40 years, but little is known of its mechanism of action. The primary indication for clofazimine is multibacillary leprosy, but it is useful in several infectious and noninfectious diseases, such as atypical mycobacterial infections, rhinoscleroma, pyoderma gangrenosum, necrobiosis lipoidica, severe acne, pustular psoriasis, and discoid lupus erythematosus. Postulated mechanisms of action include intercalation of clofazimine with bacterial DNA and increasing levels of cellular phospholipase A2. Clinical experience, possible mechanisms of action, and side effects of clofazimine are summarized.

引用

收藏

页码：241 / 247

页数：7

相关论文

共 93 条

[41] SUCCESSFUL TREATMENT OF A PATIENT WITH CUTANEOUS MALACOPLAKIA WITH CLOFAZIMINE AND TRIMETHOPRIM-SULFAMETHOXAZOLE [J].

HERRERO, C ;

TORRAS, H ;

PALOU, J ;

MASCARO, JM .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1990, 23 (05) :947-948

[42] SURVIVAL OF PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME AND DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX INFECTION WITH AND WITHOUT ANTIMYCOBACTERIAL CHEMOTHERAPY [J].

HORSBURGH, CR ;

HAVLIK, JA ;

ELLIS, DA ;

KENNEDY, E ;

FANN, SA ;

DUBOIS, RE ;

THOMPSON, SE .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03) :557-559

[43] CURRENT CONCEPTS - MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].

HORSBURGH, CR .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (19) :1332-1338

[44] QUADRUPLE-DRUG THERAPY FOR MYCOBACTERIUM-AVIUM-INTRACELLULARE BACTEREMIA IN AIDS PATIENTS [J].

HOY, J ;

MIJCH, A ;

SANDLAND, M ;

GRAYSON, L ;

LUCAS, R ;

DWYER, B .

JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (04) :801-805

[45]

JAMET P, 1992, INT J LEPROSY, V60, P542

[46] TREATMENT OF PYODERMA-GANGRENOSUM WITH CLOFAZIMINE [J].

KAPLAN, B ;

TRAU, H ;

SOFER, E ;

FEINSTEIN, A ;

SCHEWACHMILLET, M .

INTERNATIONAL JOURNAL OF DERMATOLOGY, 1992, 31 (08) :591-593

[47] TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA IN AIDS WITH A 4-DRUG ORAL REGIMEN - RIFAMPIN, ETHAMBUTOL, CLOFAZIMINE, AND CIPROFLOXACIN [J].

KEMPER, CA ;

MENG, TC ;

NUSSBAUM, J ;

CHIU, J ;

FEIGAL, DF ;

BARTOK, AE ;

LEEDOM, JM ;

TILLES, JG ;

DERESINSKI, SC ;

MCCUTCHAN, JA .

ANNALS OF INTERNAL MEDICINE, 1992, 116 (06) :466-472

[48] ACTIVITY OF CLARITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM COMPLEX INFECTION IN BEIGE MICE [J].

KLEMENS, SP ;

DESTEFANO, MS ;

CYNAMON, MH .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (11) :2413-2417

[49] AN INVITRO COMPARISON OF THE EFFECTS OF THE PROOXIDATIVE RIMINOPHENAZINES CLOFAZIMINE AND B669 ON NEUTROPHIL PHOSPHOLIPASE-A2 ACTIVITY AND SUPEROXIDE GENERATION [J].

KRAJEWSKA, MM ;

ANDERSON, R .

JOURNAL OF INFECTIOUS DISEASES, 1993, 167 (04) :899-904

[50] EFFECTS OF CLOFAZIMINE ANALOGS AND TUMOR-NECROSIS-FACTOR-ALPHA INDIVIDUALLY AND IN COMBINATION ON HUMAN POLYMORPHONUCLEAR LEUKOCYTE FUNCTIONS INVITRO [J].

KRAJEWSKA, MM ;

ANDERSON, R ;

OSULLIVAN, JF .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1993, 15 (02) :99-111

← 1 2 3 4 5 6 7 8 9 10 →